Log in

News

  • Home
  • Resources
  • Literature Updates
  • Neoadjuvant Chemoradiotherapy Using Cisplatin and 5-Fluorouracil (PF) Versus Carboplatin and Paclitaxel (CROSS Regimen) for Esophageal Squamous Cell Carcinoma (ESCC)

Neoadjuvant Chemoradiotherapy Using Cisplatin and 5-Fluorouracil (PF) Versus Carboplatin and Paclitaxel (CROSS Regimen) for Esophageal Squamous Cell Carcinoma (ESCC)

22 Oct 2020 10:50 PM | ISDE Office (Administrator)

Wong, Ian Y. H.; Lam, K. O.=; Zhang, Rui Qi ; Chan, Wendy W. L.; Wong, Claudia L. Y. =; Chan, Fion S. Y. ; Kwong, Dora L. W. ; Law, Simon Y. K.

Read the full abstract here...

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software